RSPO2 and acute lymphoblastic leukemia: There are several oncogenic proteins such as EPHA3 and RSPO1, RSPO2, and RSPO3, which are overexpressed in lung adenocarcinomas and lymphoblastic leukemia and define the patient’s survival rates [80,81,82].